Featured Research

from universities, journals, and other organizations

Data-driven machine learning effectively flags risk for post-stroke dangers

Date:
October 3, 2013
Source:
Perelman School of Medicine at the University of Pennsylvania
Summary:
A team of experts in neurocritical care, engineering, and informatics have devised a new way to detect which stroke patients may be at risk of a serious adverse event following a ruptured brain aneurysm.

A team of experts in neurocritical care, engineering, and informatics, with the Perelman School of Medicine at the University of Pennsylvania, have devised a new way to detect which stroke patients may be at risk of a serious adverse event following a ruptured brain aneurysm. This new, data-driven machine learning model, involves an algorithm for computers to combine results from various uninvasive tests to predict a secondary event. Preliminary results were released at the Neurocritical Care Society Annual Meeting in Philadelphia.

Comparing 89 patient cases retrospectively, the team found that automated features of existing ICU data were as effective as the transcranial doppler procedure currently used to detect a dangerous constriction of blood vessels in the brain. Transcranial doppler tests require a skilled technician to be available and are often only conducted once a day, and while the test is selective and accurately detects people who are risk, it is not as efficient (sensitivity of 56%) at ruling out which patients are not at greater risk of this serious adverse event .

"There is a great opportunity to utilize abundant existing data to provide guidance and clinical decision support, as this model was as effective and much less resource-intensive," said senior author Soojin Park, MD, assistant professor of Neurology at Penn. "However, while this simple method may be valuable, most ICUs don't have the IT infrastructure to synergize data in such a way."

The team plans to look at prospective cases to compare this method directly with other assessments and clinical decisions.


Story Source:

The above story is based on materials provided by Perelman School of Medicine at the University of Pennsylvania. Note: Materials may be edited for content and length.


Cite This Page:

Perelman School of Medicine at the University of Pennsylvania. "Data-driven machine learning effectively flags risk for post-stroke dangers." ScienceDaily. ScienceDaily, 3 October 2013. <www.sciencedaily.com/releases/2013/10/131003204950.htm>.
Perelman School of Medicine at the University of Pennsylvania. (2013, October 3). Data-driven machine learning effectively flags risk for post-stroke dangers. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2013/10/131003204950.htm
Perelman School of Medicine at the University of Pennsylvania. "Data-driven machine learning effectively flags risk for post-stroke dangers." ScienceDaily. www.sciencedaily.com/releases/2013/10/131003204950.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins